Evidence map›Paper›PMID 37973953›Full record

ArticleNature genetics2023

Primate-specific ZNF808 is essential for pancreatic development in humans.

Elisa De Franco, Nick D L Owens, Hossam Montaser, Matthew N Wakeling, Jonna Saarimäki-Vire, Athina Triantou, Hazem Ibrahim, Diego Balboa, Richard C Caswell, Rachel E Jennings and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Neonatal diabetes mellitus around the world: Update 2024.Journal of diabetes investigation · 2024
    Review
  18. Review
  19. Article
  20. New ingredients for old recipes.Nature genetics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 20 institutions in 10 countries.

Elisa De Franco *Institute of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK.ORCID 0000-0002-1437-7891
Nick D L Owens *Institute of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK.ORCID 0000-0002-2151-9923
Hossam Montaser *Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Matthew N WakelingInstitute of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK.ORCID 0000-0002-6542-9241
Jonna Saarimäki-VireStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Athina TriantouDepartment of Genetics, University of Cambridge, Cambridge, UK.
Hazem IbrahimStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-0165-2660
Diego BalboaRegulatory Genomics and Diabetes, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0002-4784-5452
Richard C CaswellGenomics Laboratory, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.ORCID 0000-0003-0713-4602
Rachel E JenningsDivision of Diabetes, Endocrinology & Gastroenterology, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
Jouni A KvistStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4089-8877
Matthew B JohnsonInstitute of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK.
Sachin MuralidharanStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Sian EllardGenomics Laboratory, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Caroline F WrightInstitute of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK.ORCID 0000-0003-2958-5076
Sateesh MaddirevulaDepartment of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Fowzan S AlkurayaDepartment of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.ORCID 0000-0003-4158-341X
Pancreatic Agenesis Gene Discovery Consortium
Neil A HanleyDivision of Diabetes, Endocrinology & Gastroenterology, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.ORCID 0000-0003-3234-4038
Sarah E FlanaganInstitute of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK.ORCID 0000-0002-8670-6340
Timo OtonkoskiStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. timo.otonkoski@helsinki.fi.ORCID 0000-0001-9190-2496
Andrew T HattersleyInstitute of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK. A.T.Hattersley@exeter.ac.uk.ORCID 0000-0001-5620-473X
Michael ImbeaultDepartment of Genetics, University of Cambridge, Cambridge, UK. mi339@cam.ac.uk.ORCID 0000-0002-0073-0922
University of Exeter · GBUniversity of Helsinki · FIAlfaisal University · SAFarwaniya Hospital · KWKing Faisal Specialist Hospital & Research Centre · SARoyal Devon & Exeter NHS Foundation Trust · GBUniversity of Cambridge · GBUniversity of Manchester · GBAin Shams University · EGCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESChildren's Hospital Mansoura University · EGFalun Hospital · SEGreat Ormond Street Hospital for Children NHS Foundation Trust · GBHaseki Eğitim ve Araştırma Hastanesi · TRImperial College London Diabetes Centre · AEKing Abdulaziz University · SALuton and Dunstable University Hospital NHS Foundation Trust · GBPrince Mohammed bin Abdulaziz Hospital · SASoliman Fakeeh Hospital · SAUniversity of Khartoum · SD

Funding

Diabetes UK 19/005971Diabetes UK 20/0006263Wellcome Trust
6 · The paper itself

Abstract

Identifying genes linked to extreme phenotypes in humans has the potential to highlight biological processes not shared with all other mammals. Here, we report the identification of homozygous loss-of-function variants in the primate-specific gene ZNF808 as a cause of pancreatic agenesis. ZNF808 is a member of the KRAB zinc finger protein family, a large and rapidly evolving group of epigenetic silencers which target transposable elements. We show that loss of ZNF808 in vitro results in aberrant activation of regulatory potential contained in the primate-specific transposable elements it represses during early pancreas development. This leads to inappropriate specification of cell fate with induction of genes associated with liver identity. Our results highlight the essential role of ZNF808 in pancreatic development in humans and the contribution of primate-specific regions of the human genome to congenital developmental disease.

Indexed as

Congenital AbnormalitiesDNA-Binding ProteinsDNA Transposable ElementsPancreasAnimalsCell DifferentiationGenome, HumanHumansPrimatesDNA-Binding ProteinsDNA Transposable ElementsZNF808 protein, human

Identifiers

PMID37973953
PMCPMC10703691
OpenAlexW4388722062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.